PHARMACEUTICAL COMPOSITION CONTAINING BOTULINUM NEUROTOXIN A2
A composition, medicament or use, comprising or consisting of botulinum toxin type A2 and a surfactant, having one or more or all of the characteristics selected from the group consisting of : (a) a much longer duration of action; (b) a much faster rate of onset of muscular paralysis; (c) a signific...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A composition, medicament or use, comprising or consisting of botulinum toxin type A2 and a surfactant, having one or more or all of the characteristics selected from the group consisting of :
(a) a much longer duration of action;
(b) a much faster rate of onset of muscular paralysis;
(c) a significantly greater intramuscular safety margin;
(d) a selective action on inhibition of skeletal muscle contraction;
(e) a selective action on inhibition of pain-related (nociceptive) nerve cell function, wherein each characteristic is determined comparative to the same characteristic effect of botulinum toxin type A1. |
---|